The impact of age and gender on cardiac resynchronization therapy outcome

Omeed Zardkoohi1, Veena Nandigam, Lorne Murray

  • 1Cardiac Arrhythmia Service, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

Insights

Cardiac resynchronization therapy (CRT) outcomes are not significantly affected by patient age, gender, or heart failure cause. This study found no major differences in long-term results across these demographic and etiological groups.

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Medical Device Therapy

Background:

  • Cardiac resynchronization therapy (CRT) is used for heart failure but outcomes vary.
  • Factors like age, gender, and heart failure cause may influence CRT effectiveness.
  • Understanding these influences is crucial for optimizing patient care.

Purpose of the Study:

  • To investigate the impact of age, gender, and heart failure etiology on long-term CRT outcomes.
  • To identify patient subgroups that may benefit differently from CRT.

Main Methods:

  • A cohort of 117 patients with advanced heart failure receiving CRT were followed for one year.
  • The primary endpoint combined heart failure hospitalization and all-cause mortality.
  • Statistical analyses included Kaplan-Meier and Breslow-Wilcoxon tests, with Cox regression for covariate adjustment.

Main Results:

  • No significant differences in CRT outcomes were observed based on age (>70 vs <70), gender (male vs female), or heart failure etiology (ischemic vs non-ischemic).
  • A trend towards worse outcomes was noted in women with ischemic cardiomyopathy, but this did not reach statistical significance after adjustment.
  • Overall, baseline characteristics were comparable across subgroups.

Conclusions:

  • In this single-institution study, cardiac resynchronization therapy outcomes appear independent of age, gender, and heart failure etiology.
  • Further research may be needed to explore potential subgroup variations in larger, multi-center studies.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...